Example: Heart Attack
Clinical Trials on Mucopolysaccharidosis II
Total 70 results
-
NCT04573023Not yet recruitingConditions: Mucopolysaccharidosis II
-
NCT04348136Active, not recruitingConditions: Mucopolysaccharidosis II
-
NCT03708965Active, not recruitingConditions: Mucopolysaccharidosis II
-
NCT03568175CompletedConditions: Mucopolysaccharidosis II
-
NCT03359213CompletedConditions: Mucopolysaccharidosis II
-
NCT02262338CompletedConditions: Mucopolysaccharidosis II
-
NCT04591834RecruitingConditions: Mucopolysaccharidosis II
-
NCT04251026RecruitingConditions: Mucopolysaccharidosis II
-
NCT02663024Unknown statusConditions: Mucopolysaccharidosis II
-
NCT03529786Active, not recruitingConditions: Mucopolysaccharidosis II
-
NCT01301898CompletedConditions: Mucopolysaccharidosis II
-
NCT03128593CompletedConditions: Mucopolysaccharidosis II
-
NCT00069641CompletedConditions: Mucopolysaccharidosis II
-
NCT03041324Active, not recruitingConditions: Mucopolysaccharidosis II; MPS II
-
NCT00004454CompletedConditions: Mucopolysaccharidosis II
-
NCT02044692Unknown statusThe Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) PatientsConditions: Hunter Syndrome
-
NCT04597385Enrolling by invitationConditions: Mucopolysaccharidosis II
-
NCT01602601CompletedConditions: Mucopolysaccharidosis II
-
NCT04007536RecruitingConditions: Hunter Syndrome
-
NCT00630747CompletedConditions: Hunter Syndrome; Mucopolysaccharidosis II (MPS II)
-
NCT02455622Active, not recruitingConditions: Hunter Syndrome
-
NCT04571970RecruitingConditions: Mucopolysaccharidosis Type II (MPS II)
-
NCT03566043RecruitingConditions: Mucopolysaccharidosis Type II (MPS II)
-
NCT01449240CompletedConditions: Hunter Syndrome
-
NCT00607386CompletedConditions: Hunter Syndrome; Mucopolysaccharidosis II; MPS II